Legend Biotech Corp-adr (LEGN) Institutional Investor Snapshot (221 Funds, Q2 2026)

LEGN ranks #2778 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

LEGN is a top-conviction position for Hhlr Advisors, LTD. — at 20.8% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in LEGN belongs to FMR LLC, but the position matters far more to Hhlr Advisors, LTD., who has 20.8% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Y-Intercept has trimmed its LEGN position for two straight quarters, cutting it by $3.5M while still holding $555.1K.

LEGN is down 6.7% today, but institutions show net buying of $364.1M this quarter — a divergence between today's price move and the underlying institutional flow.

LEGN reported a net loss of $296.8M over the trailing twelve months.

• Not yet profitable — net loss of $296.8M over the trailing twelve months
• Revenue grew 74.7% year over year
• Net income declined year over year, from -$177.0M to -$296.8M
• Operating cash flow was negative, using $100.2M in cash
• Current ratio of 1.96x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.42x equity — within a conventional range